Determination of Candesartan Concentration in Human Plasma by HPLC-Fluorometric Method and Bioequivalence of Candesartan Cilexetil Preparations
ZHANG Le,ZHOU Shi-wen,XU Ying,YING Yi,HUANG Yong-ping,TANG Jian-lin
DOI: https://doi.org/10.6039/j.issn.1001-0408.2013.06.16
2013-01-01
Abstract:OBJECTIVE:To establish an accurate and sensitive method for the determination of candesartan concentration in human plasma,and to study the bioequivalence of 2 candesartan cilexetil preparations.METHODS:Plasma samples were treated with aether and determined by HPLC Fluoremetric method.The determination was performed on Diamonsil C 18 column with mobile phase consisted of methanol-0.02 mol/L potassium dihydrogen phosphate buffer(66:34,pH adjusted to 4 using phosphoric acid)using valsartan as internal standard.Excitation wavelength and emission wavelength of fluorescence detection were 265 nm and 395 nm,respectively.The pharmacokinetics parameters were compared between candesartan cilexetil capsuals(test preparation)and tablets(reference preparation).RESULTS:The linear range of candesartan was 0.98-500 ng/m(lr=0.999 7,n=2).The absolute recovery and relative recovery at low,medium,high concentrations were 95.89%,101.82%,100.75 and 99.9%,99.8%,103.7%.The intra-day and inter-day RSD were 3.2%-9.0% and 4.2%-7.8%(n=5),respectively.90% confidence limit of test preparation of the logarithmic transformed parameters AUC 0-36 h,AUC 0-∞,c max were in 80.4%-107.3%,80.2%-107.0%,80.1%-111.6% vs.the reference preparation,respectively.No significant difference was found by nonparametric test of t max.CONCLUSION:The method is simple and sensitive and suitable for the determination of candesartan concentration in plasma.2 preparations are bioequivalent.